PATRICIA MICKUNAS: Open Payments
NPI 1992965370 · ATHENS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 44 payments from 8 companies in 2025. Trend: 2023 $354 · 2024 $401 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $351 |
| Otsuka America Pharmaceutical, Inc. | 9 | $140 |
| Alkermes, Inc. | 6 | $110 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: CAPLYTA, REXULTI, ARISTADA, TRINTELLIX, Auvelity, SPRAVATO.
Industry payments across OH — which companies pay providers there.
